Log in

ICCM IceCure Medical Ltd. NASDAQ · United States

IceCure Medical (ICCM) news

Company Updates ·

Lifeward names Ronen Tsimerman chief financial officer

The board appointed Ronen Tsimerman as chief financial officer, effective November 1, 2026. His employment agreement is subject to shareholder approval of a renewed compensation policy.

Latest IceCure Medical news

We have not published a story on IceCure Medical yet. When there is news, it will appear here.

IceCure Medical annual financials

LineFY2025FY2024
Revenue$3.4 million$3.3 million
Research and development$7.4 million$7.1 million
Net income (loss)-$15.1 million-$15.3 million
Cash from operations-$14.6 million-$12.6 million
Cash and equivalents$8.9 million$7.6 million

Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $8.9 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about IceCure Medical

What is the ticker symbol of IceCure Medical?

IceCure Medical Ltd. trades under the ticker ICCM on NASDAQ.

Where is IceCure Medical listed?

IceCure Medical Ltd. is listed on NASDAQ.

Which country or territory is IceCure Medical listed under?

Our directory records IceCure Medical Ltd. under United States.

Does aibio.space cover IceCure Medical?

aibio.space lists IceCure Medical Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

What was IceCure Medical's revenue last year?

$3.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is IceCure Medical profitable?

IceCure Medical Ltd. reported a net loss of $15.1 million for the fiscal year ended Dec 31, 2025, and used $14.6 million of cash in operations, per its annual report to the SEC.

How much does IceCure Medical spend on research and development?

$7.4 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does IceCure Medical have?

$8.9 million in cash at Dec 31, 2025, per its 20-F.

Which other companies' news mentions IceCure Medical?

IceCure Medical is named in 1 of our story about other companies, most recently: "Lifeward names Ronen Tsimerman chief financial officer" (Oct 27, 2026). Source.

How can I follow IceCure Medical (ICCM) news?

Press Follow on this page to add IceCure Medical to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming IceCure Medical so far, in Company Updates.

Investor discussion: IceCure Medical

Members talk about IceCure Medical (ICCM). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at IceCure Medical, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a reverse stock split. SEC Form 6-K. Source

  2. Financings

    Reported a financing. SEC Form 6-K. Source

  3. Legal

    Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 6-K. Source

  4. Financings

    Reported a financing. SEC Form 6-K. Source

  5. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

  6. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

  7. Financings

    Reported a financing. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:ICCM on TradingView.

Listing details

IceCure Medical Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ICCM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
IceCure Medical Ltd.
Ticker
ICCM
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.